R&D-performing Small and Medium-sized companies (SMEs) are the entrepreneurial stars of Europe. Responding to their specific needs, the Commission has adopted today EUROSTARS, a new Joint Programme with 27 EUREKA countries to finance R&D partnerships with research-performing SMEs.
In addition to the Commission contribution of EUR 100 million, 22 EU Member states (1) and 5 countries associated to FP7 (2) will jointly contribute another EUR 300 million, giving a total investment of EUR 400 million over 6 years. This will, in turn, mobilise up to EUR 400 million in additional private funding, resulting in an estimated EUR 800 million package to support European R&D performing SMEs. Through EUROSTARS, participating countries will pool their national programmes and research funding in favour of SMEs, resulting in better, more efficient use of funds.
Commissioner Potocnik said "EUROSTARS brings a new level of cooperation and integration between Community and national research programmes. Creating strong links between public and private funding, EUROSTARS will give a boost to R&D performing SMEs, allowing them to collaborate with the best research teams in Europe, and to transform new ideas into successful businesses. It is an illustration of the European Research Area at work".
SMEs represent 99% of all enterprises in Europe and are crucial to the success of the renewed Lisbon partnership for growth and jobs. Among these, R&D-performing SMEs have a key role to play. With their small size, flexible organisation and commitment to research, they can take advantage of a fast-changing economic environment, seize new market opportunities, and create new jobs.
EUROSTARS is one of several areas identified for a higher level of research co-operation among the Member States, with the Commission participating actively. The idea is to go beyond the mere coordination of research programmes: such programmes encompass a voluntary integration process covering scientific, management and financial aspects of research projects. This includes
- scientific integration, which entails common definition of priorities, and common evaluation and selection of projects, on the basis of excellence and economic impact
- management integration through the establishment of a dedicated management structure for faster decision-making, and
- financial integration, which includes setting up a multi-annual financing plan, pooling EC and Member States funds into a common pot.
The EUROSTARS Joint Programme is directly tailored to the needs of R&D-performing SMEs. It will target R&D activities
- involving multi-partner multi-national projects, led by SMEs, but open to other types of participants (universities, research organisations, large companies)
- executed principally by R&D-performing SMEs
- targeted at market-oriented research and development, aiming at short to medium term commercial results
EUROSTARS will be managed by the EUREKA Secretariat in Brussels, under the authority of the Eurostars High Level Group of representatives of the participating countries. Providing a "one stop shop" for SMEs, the Secretariat will issue calls, receive project proposals, organise evaluation by independent experts, manage the financial contributions to the Joint Programme, and monitor project progress.
EUREKA is intergovernmental Initiative launched in 1985, to support market-oriented R&D and innovation projects by industry, research centres and universities across all sectors. It is composed of 38 members, including the European Community. With its flexible and decentralised Network, EUREKA offers project partners rapid access to skills and expertise across Europe and national public and private funding schemes . By encouraging and assisting businesses to innovate, EUREKA is fully complementary with the 7 th Framework Programme in working actively towards the common European objective of raising investment in R&D to 3% of GDP by 2010(1) Austria, Belgium, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, the Netherlands, Poland, Portugal, Romania, Slovenia, Spain and Sweden
(2) Iceland, Israel, Norway, Switzerland and Turkey
Patrick Vittet-Philippe | alfa
Blockchain Set to Transform the Financial Services Market
28.09.2016 | HHL Leipzig Graduate School of Management
Paper or plastic?
08.07.2016 | University of Toronto
Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion
Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
25.10.2016 | Life Sciences
24.10.2016 | Earth Sciences
24.10.2016 | Life Sciences